Chinanews.com, Beijing, November 28th. On the 27th, the 11th China Hypertension Conference (2021) of the Chinese Medical Doctor Association was opened online. The participating experts conducted in-depth discussions on the current status, trends, and prevention and treatment of cardiovascular diseases in China. Explore exchanges.
The conference was sponsored by the Chinese Medical Doctor Association and the Chinese Medical Doctor Association Hypertension Professional Committee, co-organized by the Chinese Medical Association Cardiovascular Branch and the Chinese Medical Education Association Hypertension Professional Committee, and undertaken by the Second Affiliated Hospital of Chongqing Medical University.
Yang Min, Vice President of the Chinese Medical Doctor Association, Academician Ge Junbo, Director of the Department of Cardiology, Zhongshan Hospital Affiliated to Fudan University, Academician Gu Dongfeng, Acting Vice President of Southern University of Science and Technology, Sun Yingxian, Chairman of the Hypertension Professional Committee of the Chinese Medical Doctor Association, No. 1 in the Hypertension Professional Committee of the Chinese Medical Doctor Association Chairman Zhao Lianyou, Vice President of Chongqing Medical University Yuan Jun, and Secretary of the Party Committee of the Second Affiliated Hospital of Chongqing Medical University Wang Dagang attended the opening ceremony of the conference.
Ge Junbo said at the conference that there are nearly 300 million people with hypertension in my country, and the average annual cost of treatment of cardiovascular and cerebrovascular diseases is increasing at a rate of 10% per year, and the burden of cardiovascular disease in my country is huge.
Hypertension is the primary cardiovascular risk factor, and it has the characteristics of low treatment rate and low control rate. Therefore, how to effectively manage blood pressure has become an important issue for cardiovascular physicians.
Ge Junbo gave a keynote report entitled "Development and Prospects of Panvascular Medicine".
Ge Junbo pointed out that the human blood vessels should be studied and prevented as a whole, which is collectively referred to as pan-vascular disease.
He expounded on three aspects: early prevention of pan-vascular disease; evaluation of the role of new technologies and theories in the diagnosis and progress of pan-vascular disease; and exploration of the clinical practice model of pan-vascular disease.
He pointed out that in the future, my country should build a pan-vascular disease panoramic management model that integrates preventive diagnosis and treatment, scientific research, and innovation.
Gu Dongfeng said at the conference that since the country launched a series of macro policies such as the "Healthy China Strategy" and the "Healthy China 2030" Planning Outline, my country's cardiovascular disease prevention and control have important institutional guarantees, including hypertension, diabetes, etc. The prevention and treatment of diseases is also changing from disease treatment to prevention of risk factors.
He said that in the future, on the one hand, we should strengthen the integration of Internet wearables, health management and other technologies, and promote a new cardiovascular disease management model; on the other hand, we should further improve the academic level and the training of hypertension prevention and treatment personnel, especially primary hypertension. The training of medical personnel for prevention and treatment will ultimately realize the precise prevention and control of cardiovascular diseases.
Zhao Lianyou said that in recent years, my country has made great progress in the prevention and control of hypertension, but the prevalence, disability and mortality rates of hypertension in my country are still maintained at a high level, and the cost of hypertension treatment is also increasing year by year.
In the face of the above problems, the state has further standardized the hypertension prevention and control system in the "Healthy China Strategy" and the "Healthy China 2030" Plan.
He said that in the future, we should build a new hypertension prevention and control system with government leadership, medical care as the mainstay, and participation of social groups and patients; strengthen the construction of hypertension prevention and treatment personnel, especially the training of basic hypertension talents; pay attention to standardization and individualization Hypertension treatment; promote standardized hypertension management models, highlight the first-line role of primary medical institutions in hypertension management, and finally realize the full implementation of national policies.
The organizer introduced that the main theme of this conference is "inheritance, innovation, intelligence, cross-border, and sharing", with a view to promoting the scientific evaluation, diagnosis and treatment innovation, scientific management and system construction of my country's hypertension.
The conference combines the latest research progress in the field of hypertension at home and abroad and guidelines for the prevention and treatment of hypertension at home and abroad, aiming to comprehensively improve the capabilities of prevention management, comprehensive diagnosis, comprehensive treatment, prevention and rehabilitation, and discuss hypertension and related diseases in an all-round, multi-angle, and multi-level manner New technologies, new methods, new ideas and interdisciplinary development models related to clinical prevention and treatment, basic research, epidemiology, and social medicine.
(over)